| ［1］ |
Davies B, Turner KM, Frølund M, et al. Risk of reproductive complications following chlamydia testing: a population⁃based retrospective cohort study in Denmark［J］. Lancet Infect Dis, 2016, 16（9）: 1057⁃1064. DOI: 10.1016/S1473⁃3099（16）30092⁃5.
|
| ［2］ |
Rekart ML, Gilbert M, Meza R, et al. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy［J］. J Infect Dis, 2013, 207（1）: 30⁃88. DOI: 10.1093/infdis/jis644.
|
| ［3］ |
World Health Organization. Global health sector strategy on sexually transmitted infections, 2016⁃2021［M］. Geneva: World Health Organization, 2016: 7⁃11. DOI: WHO/RHR/16.09.
|
| ［4］ |
Centers for disease control and prevention. 2015 sexually transmitted diseases surveillance［J/CD］. Available online at: https://wwwcdcgov/std/stats15/chlamydiahtm⁃foot⁃2. （accessed at February 8, 2017）.
|
| ［5］ |
European Centre for Disease Prevention and Control. Sexually transmitted infections in Europe 2013［M］. Stockholm: European Centre for Disease Prevention and Control, 2015: 7⁃10. DOI: 10.2900/910982.
|
| ［6］ |
岳晓丽, 龚向东, 滕菲, 等. 2008⁃2015 年中国性病监测点生殖道沙眼衣原体感染流行特征分析［J］. 中华皮肤科杂志, 2016, 49（5）: 308⁃313. DOI: 10.3760/cma.j.issn.0412⁃4030.2016.05.002.
|
| ［7］ |
Schust DJ, Ibana JA, Buckner LR, et al. Potential mechanisms for increased HIV⁃1 transmission across the endocervical epithelium during C. trachomatis infection［J］. Curr HIV Res, 2012, 10（3）: 218⁃227.
|
| ［8］ |
Peipert JF. Clinical practice. Genital chlamydial infections［J］. N Engl J Med, 2003, 349（25）: 2424⁃2430. DOI: 10.1056/NEJMcp030542.
|
| ［9］ |
Haggerty CL, Gottlieb SL, Taylor BD, et al. Risk of sequelae after Chlamydia trachomatis genital infection in women［J］. J Infect Dis, 2010, 201（Suppl 2）: S134⁃155. DOI: 10.1086/652395.
|
| ［10］ |
Mylonas I. Female genital Chlamydia trachomatis infection: where are we heading?［J］. Arch Gynecol Obstet, 2012, 285（5）: 1271⁃1285. DOI: 10.1007/s00404⁃012⁃2240⁃7.
|
| ［11］ |
Herzog SA, Heijne JC, Althaus CL, et al. Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies［J］. Sex Transm Dis, 2012, 39（8）: 628⁃637. DOI: 10.1097/OLQ.0b013e31825159ff.
|
| ［12］ |
Handsfield HH. Questioning azithromycin for chlamydial infection［J］. Sex Transm Dis, 2011, 38（11）: 1028⁃1029. DOI: 10.1097/OLQ.0b013e318227a366.
|
| ［13］ |
Scott Lamontagne D, Baster K, Emmett L, et al. Incidence and reinfection rates of genital chlamydial infection among women aged 16⁃24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group［J］. Sex Transm Infect, 2007, 83（4）: 292⁃303. DOI: 10.1136/sti.2006. 022053.
|
| ［14］ |
Batteiger BE, Tu W, Ofner S, et al. Repeated Chlamydia trachomatis genital infections in adolescent women［J］. J Infect Dis, 2010, 201（1）: 42⁃51. DOI: 10.1086/648734.
|
| ［15］ |
Walker J, Fairley CK, Urban E, et al. Maximising retention in a longitudinal study of genital Chlamydia trachomatis among young women in Australia［J］. Bmc Public Health, 2011, 11: 156. DOI: 10.1186/1471⁃2458⁃11⁃156.
|
| ［16］ |
Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection［J］. N Engl J Med, 2005, 352（7）: 676⁃685. DOI: 10.1056/NEJMoa041681.
|
| ［17］ |
Pitt RA, Alexander S, Horner PJ, et al. Presentation of clinically suspected persistent chlamydial infection: a case series［J］. Int J STD AIDS, 2013, 24（6）: 469⁃475. DOI: 10.1177/095646241247 2815.
|
| ［18］ |
Khosropour CM, Dombrowski JC, Barbee LA, et al. Comparing azithromycin and doxycycline for the treatment of rectal chlamydial infection: a retrospective cohort study［J］. Sex Transm Dis, 2014, 41（2）: 79⁃85. DOI: 10.1097/OLQ.0000000000000088.
|
| ［19］ |
Yin YP, Peeling RW, Chen XS, et al. Clinic⁃based evaluation of Clearview Chlamydia MF for detection of Chlamydia trachomatis in vaginal and cervical specimens from women at high risk in China［J］. Sex Transm Infect, 2006, 82（Suppl 5）: v33⁃v37. DOI: 10.1136/sti.2006.022475.
|
| ［20］ |
Simms I, Warburton F, Weström L. Diagnosis of pelvic inflam⁃matory disease: time for a rethink［J］. Sex Transm Infect, 2003, 79（6）: 491⁃494. DOI: 10.1136/sti.79.6.491.
|
| ［21］ |
Centers for Disease Prevention and Control. 2015 STD Treatment Guidelines［S］. https://www.cdc.gov/std/tg2015/chlamydia.htm（accessed at February 28, 2017）.
|
| ［22］ |
Baud D, Regan L, Greub G. Emerging role of Chlamydia and Chlamydia⁃like organisms in adverse pregnancy outcomes［J］. Curr Opin Infect Dis, 2008, 21（1）: 70⁃76. DOI: 10.1097/QCO. 0b013e3282f3e6a5.
|
| ［23］ |
Howie SE, Horner PJ, Horne AW. Chlamydia trachomatis infection during pregnancy: known unknowns［J］. Discov Med, 2011, 12（62）: 57⁃64.
|
| ［24］ |
Baud D, Goy G, Jaton K, et al. Role of Chlamydia trachomatis in miscarriage［J］. Emerg Infect Dis, 2011, 17（9）: 1630⁃1635. DOI: 10.3201/eid1709.100865.
|
| ［25］ |
Centers for Disease Prevention and Control. Recommendations for the laboratory⁃based detection of Chlamydia trachomatis and Neisseria gonorrhoeae—2014［J］. MMWR, 2014, 63（RR02）: 1⁃19. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6302a1.htm（accessed at February 28, 2017）.
|
| ［26］ |
中国疾病控制中心性病控制中心, 中华医学会皮肤性病学分会性病学组, 中国医师协会皮肤科医师分会性病亚专业委员会: 梅毒、淋病、生殖器疱疹、生殖道沙眼衣原体感染诊疗指南（2014）［J］. 中华皮肤科杂志, 2014, 47（5）: 365⁃372. DOI: 10. 3760/cma.j.issn.0412⁃4030.2014.05.022.
|
| ［27］ |
Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta⁃analysis of randomized clinical trials［J］. Sex Transm Dis, 2002, 29（9）: 497⁃502.
|
| ［28］ |
Kong FY, Tabrizi SN, Fairley CK, et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta⁃analysis［J］. J Antimicrob Chemother, 2015, 70（5）: 1290⁃1297. DOI: 10.1093/jac/dku574.
|
| ［29］ |
Lanjouw E, Ouburg S, de Vries HJ, et al. 2015 European guideline on the management of Chlamydia trachomatis infections［J］. Int J STD AIDS, 2016, 27（5）: 333⁃348. DOI: 10.1177/0956462415618837.
|
| ［30］ |
Cowan FM, French R, Johnson AM. The role and effectiveness of partner notification in STD control: a review［J］. Genitourin Med, 1996, 72（4）: 247⁃252.
|
| ［31］ |
Gottlieb SL, Deal CD, Giersing B, et al. The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps［J］. Vaccine, 2016, 34（26）: 2939⁃2947. DOI: 10.1016/j.vaccine.2016.03.111.
|
| ［32］ |
Gottlieb SL, Johnston C. Future prospects for new vaccines against sexually transmitted infections［J］. Curr Opin Infect Dis, 2017, 30（1）: 77⁃86. DOI: 10.1097/QCO.0000000000000343.
|
